PharmaShots | Incisive News in 3 Shots

Subscribe Now

Progressive Phenotype

Boehringer Ingelheim's Ofev (nintedanib) as the First Treatment for Chronic Fibrosing ILDs with Progressive Phenotype

Boehringer Ingelheim's Ofev (nintedanib) as the First Treatment for Chronic Fibrosing ILDs with Progressive Phenotype

March 10, 2020

Boehringer Ingelheim's Ofev (nintedanib) Receives the US FDA's Breakthrough Therapy Designation for Chronic Fibrosing ILDs with a Progressive Phenotype

Boehringer Ingelheim's Ofev (nintedanib) Receives the US FDA's Breakthrough Therapy Designation for Chronic Fibrosing ILDs with a...

October 11, 2019

Contact Us

First Floor, B-66, Sector 63 Noida, Uttar Pradesh, INDIA - 201301
+91-120 428 0707
connect@pharmashots.com
Newsletter

Our Information

Follow Us